Thymoma natural history: Difference between revisions
No edit summary |
|||
(17 intermediate revisions by 4 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
If left untreated thymoma may progress to invade the mediastinum and the surrounding | If left untreated, thymoma may progress to invade the [[mediastinum]] and the surrounding structures. Depending on the [[Cancer staging|stage]] of the [[tumor]] at the time of [[diagnosis]], the [[prognosis]] may vary. The [[prognosis]] is generally regarded as good. Common [[Complication (medicine)|complications]] of thymoma include the [[Mass effect (medicine)|pressure effect]] of the mass itself, [[autoimmune diseases]], and rarely, progression to [[malignancy]]. | ||
===Natural | |||
The | ==Natural History, Complications, and Prognosis== | ||
===Natural History=== | |||
*One-third of the [[Tumor|tumors]] are discovered because of an associated [[autoimmune disorder]]. | |||
*The most common of these [[Autoimmune disorder|autoimmune disorders]] is [[myasthenia gravis]]: 10 - 15% of [[Patient|patients]] with [[myasthenia gravis]] have thymoma. And 30 - 45% of [[Patient|patients]] with thymoma have [[myasthenia gravis]]. | |||
*[[Patient|Patients]] with thymoma demonstrate a tendency for local [[Mediastinum|mediastinal]] recurrence and [[pleural]] ‘‘droplet’’ recurrence presumably caused by [[Mediastinal pleura|mediastinal pleural]] [[Invasive (medical)|invasion]] after [[resection]].<ref name="www.ncbi.nlm.nih.gov">{{Cite web | last = | first = | title = Results of surgical treatment for t... [J Thorac Cardiovasc Surg. 1984] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/6690858 | publisher = | date = | accessdate = }}</ref> | |||
===Complications=== | ===Complications=== | ||
[[Complication (medicine)|Complications]] associated with thymoma include: | |||
* Pressure effect associated with thymoma (sometimes | *[[Mass effect (medicine)|Pressure effect]] associated with thymoma (sometimes presenting as [[superior vena cava syndrome]]) | ||
* Autoimmune diseases associated with thymoma ( | * [[Autoimmune diseases]] associated with thymoma ([[myasthenia gravis]] and [[pure red cell aplasia]]) | ||
* | *[[Thymic]] [[malignancy]] of unknown [[etiology]] | ||
*Rarely (approximately 7% of cases), [[metastasis]] to [[pleura]], [[bones]], [[liver]], or [[brain]]<ref name="pmid10561285">{{cite journal |author=Thomas CR, Wright CD, Loehrer PJ |title=Thymoma: state of the art |journal=[[Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology]] |volume=17 |issue=7 |pages=2280–9 |year=1999 |month=July |pmid=10561285 |doi= |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=10561285 |accessdate}}</ref> | |||
====Complications of Radiotherapy==== | ====Complications of Radiotherapy==== | ||
The most common | The most common [[complications]] of [[Radiation therapy|radiotherapy]] are:<ref name="www.ncbi.nlm.nih.gov">{{Cite web | last = | first = | title = Technical advances of radiation therapy for t... [J Thorac Oncol. 2010] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/20859129 | publisher = | date = | accessdate = }}</ref> | ||
*[[Pulmonary fibrosis]] | |||
*[[Pericarditis]] | |||
*[[Myelitis]] | |||
====Complications of Surgery==== | ====Complications of Surgery==== | ||
The most common [[Complication (medicine)|complications]] of [[thymectomy]] are: | |||
*Recurrence | *[[Complication (medicine)|Complications]] of the procedure, such as: | ||
*Live attenuated [[vaccines]] such as [[yellow fever]] vaccine may have adverse | **[[Bleeding]] | ||
**[[Infection]] | |||
**Damage to other [[Organ (anatomy)|organs]] | |||
**[[Nerve injury|Nerve injuries]] ([[bilateral]] [[phrenic nerve]] injury) | |||
**[[Respiratory failure]] | |||
*Recurrence has been described 10 to 20 years after removal of the [[Primary tumor|primary lesion]], necessitating long-term follow up. | |||
*Live attenuated [[vaccines]], such as [[yellow fever]] vaccine, may have [[adverse effects]] after [[thymectomy]] due to an inadequate [[T cell|T-cell]] response. | |||
====Complications of Thymic Biopsy==== | ====Complications of Taking Thymic Biopsy==== | ||
The [[Complication (medicine)|complications]] of taking [[Thymus|thymic]] [[biopsy]] include: | |||
*[[Pneumothorax]] | |||
*[[Mediastinitis]] | |||
===Prognosis=== | ===Prognosis=== | ||
The | The [[prognosis]] of thymoma depends on the following: | ||
*Location of the [[tumor]] | |||
*[[Cancer staging|Stage]] of the [[tumor]] | |||
* | |||
* | |||
*The | :*The [[prognosis]] is much worse for stage III or IV thymoma as compared to stage I and II [[Tumor|tumors]] | ||
* | :*[[Patient|Patients]] with stage III and IV [[Tumor|tumors]] may nonetheless survive for several years with appropriate [[Oncology|oncological]] management | ||
*[[Resection|Resectability]] of the [[tumor]] | |||
*[[Patient|Patient's]] general [[health]] | |||
*Primary [[diagnosis]] vs. recurrence | |||
*[[Histology|Histologic]] type (mixed [[Histology|histologic]] type is associated with the worst [[prognosis]])<ref name="www.ncbi.nlm.nih.gov">{{Cite web | last = | first = | title = A review of prognostic factors in thymic mali... [J Thorac Oncol. 2011] - PubMed - NCBI | url = http://www.ncbi.nlm.nih.gov/pubmed/21847050 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Line 45: | Line 59: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Surgery]] |
Latest revision as of 23:04, 8 August 2019
Thymoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymoma natural history On the Web |
American Roentgen Ray Society Images of Thymoma natural history |
Risk calculators and risk factors for Thymoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2] Ahmad Al Maradni, M.D. [3]
Overview
If left untreated, thymoma may progress to invade the mediastinum and the surrounding structures. Depending on the stage of the tumor at the time of diagnosis, the prognosis may vary. The prognosis is generally regarded as good. Common complications of thymoma include the pressure effect of the mass itself, autoimmune diseases, and rarely, progression to malignancy.
Natural History, Complications, and Prognosis
Natural History
- One-third of the tumors are discovered because of an associated autoimmune disorder.
- The most common of these autoimmune disorders is myasthenia gravis: 10 - 15% of patients with myasthenia gravis have thymoma. And 30 - 45% of patients with thymoma have myasthenia gravis.
- Patients with thymoma demonstrate a tendency for local mediastinal recurrence and pleural ‘‘droplet’’ recurrence presumably caused by mediastinal pleural invasion after resection.[1]
Complications
Complications associated with thymoma include:
- Pressure effect associated with thymoma (sometimes presenting as superior vena cava syndrome)
- Autoimmune diseases associated with thymoma (myasthenia gravis and pure red cell aplasia)
- Thymic malignancy of unknown etiology
- Rarely (approximately 7% of cases), metastasis to pleura, bones, liver, or brain[2]
Complications of Radiotherapy
The most common complications of radiotherapy are:[1]
Complications of Surgery
The most common complications of thymectomy are:
- Complications of the procedure, such as:
- Bleeding
- Infection
- Damage to other organs
- Nerve injuries (bilateral phrenic nerve injury)
- Respiratory failure
- Recurrence has been described 10 to 20 years after removal of the primary lesion, necessitating long-term follow up.
- Live attenuated vaccines, such as yellow fever vaccine, may have adverse effects after thymectomy due to an inadequate T-cell response.
Complications of Taking Thymic Biopsy
The complications of taking thymic biopsy include:
Prognosis
The prognosis of thymoma depends on the following:
- The prognosis is much worse for stage III or IV thymoma as compared to stage I and II tumors
- Patients with stage III and IV tumors may nonetheless survive for several years with appropriate oncological management
- Resectability of the tumor
- Patient's general health
- Primary diagnosis vs. recurrence
- Histologic type (mixed histologic type is associated with the worst prognosis)[1]
References
- ↑ 1.0 1.1 1.2 "Results of surgical treatment for t... [J Thorac Cardiovasc Surg. 1984] - PubMed - NCBI".
- ↑ Thomas CR, Wright CD, Loehrer PJ (1999). "Thymoma: state of the art". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17 (7): 2280–9. PMID 10561285. Text "accessdate" ignored (help); Unknown parameter
|month=
ignored (help)